Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA108440-02
Application #
6804998
Study Section
Special Emphasis Panel (ZCA1-GRB-V (M1))
Program Officer
Ault, Grace S
Project Start
2003-09-30
Project End
2008-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
2
Fiscal Year
2004
Total Cost
$221,160
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Rapisuwon, Suthee; Vietsch, Eveline E; Wellstein, Anton (2016) Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J 14:211-22
LaConti, Joseph J; Laiakis, Evagelia C; Mays, Anne Deslattes et al. (2015) Distinct serum metabolomics profiles associated with malignant progression in the KrasG12D mouse model of pancreatic ductal adenocarcinoma. BMC Genomics 16 Suppl 1:S1
Sharif, G M; Schmidt, M O; Yi, C et al. (2015) Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling. Oncogene 34:5879-89
Vietsch, Eveline E; van Eijck, Casper Hj; Wellstein, Anton (2015) Circulating DNA and Micro-RNA in Patients with Pancreatic Cancer. Pancreat Disord Ther 5:
Shivapurkar, Narayan; Weiner, Louis M; Marshall, John L et al. (2014) Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs. PLoS One 9:e84686
Shivapurkar, N; Mikhail, S; Navarro, R et al. (2013) Decrease in blood miR-296 predicts chemotherapy resistance and poor clinical outcome in patients receiving systemic chemotherapy for metastatic colon cancer. Int J Colorectal Dis 28:887
Wellstein, Anton (2012) ALK receptor activation, ligands and therapeutic targeting in glioblastoma and in other cancers. Front Oncol 2:192
LaConti, Joseph J; Shivapurkar, Narayan; Preet, Anju et al. (2011) Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer. PLoS One 6:e20687
Wellstein, Anton; Toretsky, Jeffrey A (2011) Hunting ALK to feed targeted cancer therapy. Nat Med 17:290-1
Stylianou, D C; Auf der Maur, A; Kodack, D P et al. (2009) Effect of single-chain antibody targeting of the ligand-binding domain in the anaplastic lymphoma kinase receptor. Oncogene 28:3296-306

Showing the most recent 10 out of 11 publications